73 related articles for article (PubMed ID: 22193059)
1. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059
[TBL] [Abstract][Full Text] [Related]
2.
Rattajak P; Aroonkesorn A; Smythe C; Wititsuwannakul R; Pitakpornpreecha T
Molecules; 2024 May; 29(9):. PubMed ID: 38731604
[TBL] [Abstract][Full Text] [Related]
3. Suppression of bone resorption by Mori Radicis Cortex through NFATc1 and c-Fos signaling-mediated inhibition of osteoclast differentiation.
Hong S; Cho HR; Kim JH; Kim M; Lee S; Yang K; Lee Y; Sohn Y; Jung HS
J Chin Med Assoc; 2024 Jun; 87(6):615-626. PubMed ID: 38651853
[TBL] [Abstract][Full Text] [Related]
4. Interactomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesis.
Tseng FJ; Chia WT; Shyu JF; Gou GH; Sytwu HK; Hsia CW; Tseng MJ; Pan RY
BMC Syst Biol; 2014 May; 8():57. PubMed ID: 24886323
[TBL] [Abstract][Full Text] [Related]
5. Potato protein hydrolysate inhibits RANKL-induced osteoclast development by inhibiting osteoclastogenic genes via the NF-κB/MAPKs signaling pathways.
Chen YJ; He YH; Lo YH; Yang HS; Abomughaid MM; Kumar KJS; Lin WT
Environ Toxicol; 2024 Jul; 39(7):3991-4003. PubMed ID: 38606910
[TBL] [Abstract][Full Text] [Related]
6. Ctdnep1 phosphatase is required for negative regulation of RANKL-induced osteoclast differentiation in RAW264.7 cells.
Konno T; Murachi H; Otsuka K; Kimura Y; Sampei C; Arasaki Y; Kohara Y; Hayata T
Biochem Biophys Res Commun; 2024 Jul; 719():150063. PubMed ID: 38749090
[TBL] [Abstract][Full Text] [Related]
7. Electroacupuncture stimulating Zusanli (ST36), Sanyinjiao (SP6) in mice with collagen-induced arthritis leads to adenosine A2A receptor-mediated alteration of p38α mitogen-activated protein kinase signaling and inhibition of osteoclastogenesis.
Zhongheng DU; Wenjie C; Kejing T; Qiqi Z; Zhiwei S; Yong C; Su Y; Chunwu Z; Tianshen YE
J Tradit Chin Med; 2023 Oct; 43(6):1103-1109. PubMed ID: 37946472
[TBL] [Abstract][Full Text] [Related]
8. Rab44, a novel large Rab GTPase, negatively regulates osteoclast differentiation by modulating intracellular calcium levels followed by NFATc1 activation.
Yamaguchi Y; Sakai E; Okamoto K; Kajiya H; Okabe K; Naito M; Kadowaki T; Tsukuba T
Cell Mol Life Sci; 2018 Jan; 75(1):33-48. PubMed ID: 28791425
[TBL] [Abstract][Full Text] [Related]
9. Nodal negatively regulates osteoclast differentiation by inducing STAT1 phosphorylation.
Kim JH; Kim K; Kim I; Seong S; Koh JT; Kim N
J Cell Physiol; 2024 Jun; 239(6):e31268. PubMed ID: 38577903
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus rhamnosus inhibits osteoclast differentiation by suppressing the TLR2/NF-κB pathway.
Fu J; Jia L; Wu L; Jiang Y; Zhao R; Du J; Guo L; Zhang C; Xu J; Liu Y
Oral Dis; 2024 May; 30(4):2373-2386. PubMed ID: 37602540
[TBL] [Abstract][Full Text] [Related]
11. Selenoprotein W engages in overactive osteoclast differentiation in multiple myeloma.
Kim H; Oh J; Kim MK; Lee KH; Jeong D
Mol Biol Rep; 2024 Apr; 51(1):587. PubMed ID: 38683225
[TBL] [Abstract][Full Text] [Related]
12. The role of osteoclast differentiation and function in skeletal homeostasis.
Ikeda K; Takeshita S
J Biochem; 2016 Jan; 159(1):1-8. PubMed ID: 26538571
[TBL] [Abstract][Full Text] [Related]
13. E proteins regulate osteoclast maturation and survival.
Long CL; Berry WL; Zhao Y; Sun XH; Humphrey MB
J Bone Miner Res; 2012 Dec; 27(12):2476-89. PubMed ID: 22807064
[TBL] [Abstract][Full Text] [Related]
14. Modulation of osteoclastogenesis with macrophage M1- and M2-inducing stimuli.
Jeganathan S; Fiorino C; Naik U; Sun HS; Harrison RE
PLoS One; 2014; 9(8):e104498. PubMed ID: 25101660
[TBL] [Abstract][Full Text] [Related]
15. Ultra-Small Lysozyme-Protected Gold Nanoclusters as Nanomedicines Inducing Osteogenic Differentiation.
Li K; Zhuang P; Tao B; Li D; Xing X; Mei X
Int J Nanomedicine; 2020; 15():4705-4716. PubMed ID: 32636626
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase Cgamma2 mediates RANKL-stimulated lymph node organogenesis and osteoclastogenesis.
Chen Y; Wang X; Di L; Fu G; Chen Y; Bai L; Liu J; Feng X; McDonald JM; Michalek S; He Y; Yu M; Fu YX; Wen R; Wu H; Wang D
J Biol Chem; 2008 Oct; 283(43):29593-601. PubMed ID: 18728019
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional characterization of bovine receptor activator of NF-κB ligand (RANKL).
Chapuis AF; Alfituri OA; Hope JC; Stevens J; Moore J; Mclean K; Androscuk D; Dry I
Vet Immunol Immunopathol; 2024 Feb; 268():110705. PubMed ID: 38157760
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclasts.
Kuroda Y; Matsuo K
World J Orthop; 2012 Nov; 3(11):167-74. PubMed ID: 23330071
[TBL] [Abstract][Full Text] [Related]
19.
Cao F; Zhou W; Liu G; Xia T; Liu M; Mi B; Liu Y
Am J Transl Res; 2017; 9(11):5022-5030. PubMed ID: 29218100
[No Abstract] [Full Text] [Related]
20. Curcuminoid (CRE-Ter)/Liposome as delivery platform for anti-osteoclastogenesis via NF-κB/ERK pathways in RANKL-induced RAW 264.7 cells through PLA foams.
Pengjam Y; Panichayupakaranant P; Tanrattanakul V
Heliyon; 2021 Sep; 7(9):e07823. PubMed ID: 34611555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
